Literature DB >> 1824337

Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy.

M Salvi1, N Bernard, A Miller, Z G Zhang, E Gardini, J R Wall.   

Abstract

We have determined the prevalences of antibodies reactive with certain pig eye muscle membrane antigens, as determined from SDS-polyacrylamide gel electrophoresis (PAGE) and western blotting, in patients with autoimmune thyroid disorders with or without associated ophthalmopathy. The most frequently detected antibody was that directed against a protein of 64 kDa. Antibodies against this antigen were detected in 33% of unselected patients with ophthalmopathy and in 75% of those with severe, active, orbital inflammation of less than 12 months duration. Such antibodies were detected also in 33% of patients with Graves' hyperthyroidism with no apparent eye disease and in 17% of patients with Hashimoto's thyroiditis with no eye disease but were not detected in patients with nonautoimmune thyroid disorders in 25 normal subjects tested. In the majority of sera showing reactivity with this protein, reactivity with membrane antigens of 55 and 95 kDa also were observed, suggesting that the three proteins were conformationally associated. Cytotoxic antibodies against human eye muscle cells, measured in antibody-dependent cell-mediated cytotoxicity (ADCC), were demonstrated in 37% of patients with ophthalmopathy. There was no significant correlation, in patients with eye disease, between positive ADCC tests and antibodies to the 64 kDa protein, the 64 kDa reactive antibody being found in 50% of patients with positive ADCC and in 35% of those with negative tests. In this study, a clear association has been shown between thyroid-associated ophthalmopathy and the detection, in immunoblotting, of antibodies reactive with a 64 kDa eye muscle membrane antigen.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1824337     DOI: 10.1089/thy.1991.1.207

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  6 in total

1.  Antibodies reactive with an intracellular epitope of a recombinant 64 kDa thyroid and eye muscle protein in patients with thyroid autoimmunity and ophthalmopathy.

Authors:  J R Wall; H Triller; A Boucher; N F Bernard; M Salvi; M Ludgate
Journal:  J Endocrinol Invest       Date:  1993-12       Impact factor: 4.256

2.  Rituximab treatment in patients with active Graves' orbitopathy: effects on proinflammatory and humoral immune reactions.

Authors:  G Vannucchi; I Campi; M Bonomi; D Covelli; D Dazzi; N Currò; S Simonetta; P Bonara; L Persani; C Guastella; J Wall; P Beck-Peccoz; M Salvi
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

3.  Failure to demonstrate cell-mediated immunity to orbital tissue antigens and epitopic fragments of a 64 kDa protein in the majority of patients with thyroid-associated ophthalmopathy.

Authors:  J Kiljanski; C Stolarski; A Barsouk; V Nebes; J R Wall
Journal:  J Endocrinol Invest       Date:  1996-05       Impact factor: 4.256

4.  Immunogenicity of a unique region of the human thyrotropin receptor.

Authors:  E V Nagy; H B Burch; Y G Lukes; F E Carr; S Kosugi; L D Kohn; K D Burman
Journal:  J Endocrinol Invest       Date:  1993 Jul-Aug       Impact factor: 4.256

5.  Two dimensional gel electrophoresis identifies minor differences in immunologically cross-reactive 64 KDa autoantigens in the thyroid and eye muscle.

Authors:  A Boucher; N Bernard; A Miller; P Rodien; M Salvi; J R Wall
Journal:  J Endocrinol Invest       Date:  1994-01       Impact factor: 4.256

Review 6.  Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon?

Authors:  T Mizokami; M Salvi; J R Wall
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.